LEVOCETIRIZINE DIHYDROCHLORIDE 2% / MUPIROCIN 2% / TRIAMCINOLONE ACETONIDE 0.025%
LEVOCETIRIZINE DIHYDROCHLORIDE 2% / MUPIROCIN 2% / TRIAMCINOLONE ACETONIDE 0.025%
Approved
Approval ID
88debe23-e0a0-1236-e053-2a95a90ac9a6
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 14, 2019
Manufacturers
FDA
Sincerus Florida, LLC
DUNS: 080105003
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LEVOCETIRIZINE DIHYDROCHLORIDE 2% / MUPIROCIN 2% / TRIAMCINOLONE ACETONIDE 0.025%
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72934-2137
Product Classification
G
Generic Name
LEVOCETIRIZINE DIHYDROCHLORIDE 2% / MUPIROCIN 2% / TRIAMCINOLONE ACETONIDE 0.025%
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 14, 2019
FDA Product Classification
INGREDIENTS (3)
MUPIROCINActive
Quantity: 2 g in 100 g
Code: D0GX863OA5
Classification: ACTIB
LEVOCETIRIZINE DIHYDROCHLORIDEActive
Quantity: 2 g in 100 g
Code: SOD6A38AGA
Classification: ACTIB
TRIAMCINOLONE ACETONIDEActive
Quantity: 0.025 g in 100 g
Code: F446C597KA
Classification: ACTIB